Join

Compare · ENOV vs EW

ENOV vs EW

Side-by-side comparison of Enovis Corporation (ENOV) and Edwards Lifesciences Corporation (EW): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ENOV and EW operate in Industrial Specialties (Health Care), so they compete in similar markets.
  • EW is the larger of the two at $48.14B, about 35.8x ENOV ($1.34B).
  • Both names hit the wire about 6 times in the past 4 weeks.
  • EW has more recent analyst coverage (25 ratings vs 19 for ENOV).
MetricENOVEW
Company
Enovis Corporation
Edwards Lifesciences Corporation
Price
-
-
Market cap
$1.34B
$48.14B
1M return
-
-
1Y return
-
-
Industry
Industrial Specialties
Industrial Specialties
Exchange
NYSE
NYSE
IPO
News (4w)
6
6
Recent ratings
19
25
ENOV

Enovis Corporation

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

EW

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Latest ENOV

Latest EW